April 3, 2017 / 12:15 PM / 4 months ago

BRIEF-Seattle Genetics presents data advancing antibody-drug conjugate at AACR annual meeting

1 Min Read

April 3 (Reuters) - Seattle Genetics Inc:

* Seattle Genetics presents data advancing antibody-drug conjugate and novel immuno-oncology programs at the American Association For Cancer Research (AACR) annual meeting Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below